-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VKyhAMPyIgVsl9xToUYO05RMptcRg7LAkAoVQkQe1f2Xr7VZo73vcCJvXm0c4aDj o5ZvXcYIYGKtTkaRj6nLLg== 0001179110-08-010714.txt : 20080528 0001179110-08-010714.hdr.sgml : 20080528 20080528071355 ACCESSION NUMBER: 0001179110-08-010714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080527 FILED AS OF DATE: 20080528 DATE AS OF CHANGE: 20080528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENTURETEC INC CENTRAL INDEX KEY: 0001134883 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 08862327 BUSINESS ADDRESS: STREET 1: FRIEDLI CORP FINANCE AG STREET 2: PRAIGUTERRASSE 5 CITY: ZURICH SWITZERLAND STATE: V8 ZIP: 00000 4 1 edgar.xml FORM 4 - X0202 4 2008-05-27 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001134883 VENTURETEC INC C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 0 1 0 Convertible Promissory Note 13.18 2008-05-27 4 P 0 2500000 13.18 A 2008-05-29 2009-11-30 Common Stock 189681 2500000 D Convertible promissory note pursuant to a private placement intended to qualify under Regulation S of the Securities Act of 1933, as amended. The Note bears interest at a rate of 4% per annum payable at maturity on November 30, 2009. This Note may be converted into common stock at any time at the option of the Holder at the conversion price of $13.18 per share. The Note automatically converts into common staock at the same conversion price if for ten consecutive trading days on the NASDAQ Global Market, the closing price equals $20.00 per share or greater. The Note is redeemable at any time by the Company upon thirty(30) days written ntoice to the Holder. Peter Friedli, President 2008-05-28 -----END PRIVACY-ENHANCED MESSAGE-----